Medical device recalls High risk

ResMed Ltd. recalls Astral 100 and Astral 150 ventilators

Recall date
September 13, 2023
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0111-2024
FDA classification
Class I
Brand / firm
ResMed Ltd.
Sold / distributed
Worldwide - US Nationwide distribution including in the states of CA, NJ, VA, IN, MI, WV, NY, WI, ND, IL, NC, FL, CO, TX, AL, LA, MD, OR, AZ, MN, WA, PA, SC, MA, ID, GA, SD, TN, NH, OH, MS, CT, IA, KY, UT, NE, MO, NV, AR, WY, RI, KS, VT, ME, OK, PR, MO, DC and the countries of Taiwan, Israel, Spain…

Why it was recalled

If ventilator is on internal battery, not intended to serve as a primary power source, low/critically low battery alarms will sound, but a fault leads to sudden power loss. If power fails, then ventilation stops and a Total Power Failure (TPF) alarm should sound, but it's powered by a supercapacitor, which degrades over time, which may cause TPF alarm to sound for less than 2 minutes or not at all

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

Astral 100 and Astral 150 ventilators

Get recall alerts

Free email alert whenever ResMed Ltd. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: ResMed Ltd.